IGFBP3 and breast cancer: Furthermore, ULR analyses indicated that BC risk was associated with three risk factors in a dose dependent manner: the IGFBP-3 rs2854744 AA genotype, DISI <9.85 mg/day, and BMI ≥24 kg/m2.